← Back to Search

Skin Barrier Oral Supplement for Rosacea

Q: Who would be eligible to participate in this investigation?

<p>Individuals with <a href="https://www.withpower.com/clinical-trials/rosacea">rosacea</a>, aged between 30 and 70 years old, are welcomed to apply for this medical trial. Approximately 24 participants will be recruited in total.</p>

N/A

Waitlist Available

Research Sponsored by Integrative Skin Science and Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Males and females 30 to 70 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial tests how taking supplements can improve skin and gut health in people with rosacea.

Who is the study for?

This trial is for men and women aged 30-70 with mild to moderate rosacea and signs of inflammation (hs-CRP >= 1.0 mg/L). Participants should not have used oral antibiotics or changed hormonal therapies recently, must agree to stop certain supplements and skin treatments before the study, and cannot be pregnant, breastfeeding, or current/recent smokers.Check my eligibility

What is being tested?

The study tests an oral supplement designed to improve skin barrier function and reduce systemic inflammation in people with rosacea. It aims to see if this supplement can alter both the skin's condition and gut health positively.See study design

What are the potential side effects?

Potential side effects are not detailed here but may include reactions related to L-Histidine or antioxidants present in the supplement. These could range from digestive discomforts to allergic responses depending on individual sensitivities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 30 and 70 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Blood hs-CRP level

Digestive Questionnaire

Fecal levels of calprotectin

+3 more

Other outcome measures

Facial erythema

Inflammatory lesions on the face

Trial Design

1Treatment groups

Experimental Treatment

Group I: Skin Barrier Oral SupplementExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Integrative Skin Science and ResearchLead Sponsor

31 Previous Clinical Trials

2,708 Total Patients Enrolled

1 Trials studying Rosacea

1,000 Patients Enrolled for Rosacea

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who would be eligible to participate in this investigation?

"Individuals with rosacea, aged between 30 and 70 years old, are welcomed to apply for this medical trial. Approximately 24 participants will be recruited in total."

Answered by AI

Are individuals over the age of 40 eligible to participate in this investigation?

"This medical trial is only open to patients between 30 and 70 years of age. However, there are 35 clinical trials for those under 18 while 271 studies are available for seniors aged 65 and above."

Answered by AI

Is registration for this trial currently open?

"According to clinicaltrials.gov, the trial was first launched on October 15th 2023 and has not sought participants since its last update on October 2nd 2023. Unfortunately, this study is inactive at present; however, there are 361 alternative trials that require enrollment presently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea

2023. "Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06072066.

All > Rosacea